Unknown

Dataset Information

0

Antitumor immunity augments the therapeutic effects of p53 activation on acute myeloid leukemia.


ABSTRACT: The negative regulator of p53, MDM2, is frequently overexpressed in acute myeloid leukemia (AML) that retains wild-type TP53 alleles. Targeting of p53-MDM2 interaction to reactivate p53 function is therefore an attractive therapeutic approach for AML. Here we show that an orally active inhibitor of p53-MDM2 interaction, DS-5272, causes dramatic tumor regressions of MLL-AF9-driven AML in vivo with a tolerable toxicity. However, the antileukemia effect of DS-5272 is markedly attenuated in immunodeficient mice, indicating the critical impact of systemic immune responses that drive p53-mediated leukemia suppression. In relation to this, DS-5272 triggers immune-inflammatory responses in MLL-AF9 cells including upregulation of Hif1α and PD-L1, and inhibition of the Hif1α-PD-L1 axis sensitizes AML cells to p53 activation. We also found that NK cells are important mediators of antileukemia immunity. Our study showed the potent activity of a p53-activating drug against AML, which is further augmented by antitumor immunity.

SUBMITTER: Hayashi Y 

PROVIDER: S-EPMC6814808 | biostudies-other | 2019 Oct

REPOSITORIES: biostudies-other

altmetric image

Publications


The negative regulator of p53, MDM2, is frequently overexpressed in acute myeloid leukemia (AML) that retains wild-type TP53 alleles. Targeting of p53-MDM2 interaction to reactivate p53 function is therefore an attractive therapeutic approach for AML. Here we show that an orally active inhibitor of p53-MDM2 interaction, DS-5272, causes dramatic tumor regressions of MLL-AF9-driven AML in vivo with a tolerable toxicity. However, the antileukemia effect of DS-5272 is markedly attenuated in immunode  ...[more]

Similar Datasets

| S-EPMC7478725 | biostudies-literature
| S-EPMC3978274 | biostudies-literature
| S-EPMC5116809 | biostudies-literature
| S-EPMC5809273 | biostudies-literature
| S-EPMC6600275 | biostudies-literature
| S-EPMC2118163 | biostudies-literature
| S-EPMC5061308 | biostudies-literature
| S-EPMC4972110 | biostudies-other
| S-EPMC10437214 | biostudies-literature
| S-EPMC4553807 | biostudies-other